PLx Pharma Inc. (PLXP) Financial Statements (2024 and earlier)

Company Profile

Business Address 9 FISHERS LANE
SPARTA, NJ 07871
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
MRQ
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including: 69,39222,44914,00114,25024,40416,700
Cash and cash equivalents 69,39222,44914,00114,25024,40416,675
Other undisclosed cash, cash equivalents, and short-term investments      25
Receivables 634 191819 
Inventory, net of allowances, customer advances and progress billings 2,458100(500)(1,003)246 
Inventory 2,458100(500)(1,003)246 
Prepaid expense    409300359
Deferred costs 2,458143 175  
Deposits current assets     4 
Other undisclosed current assets (1,466)2937631,016716(25)
Total current assets: 73,47622,98614,28314,86525,69017,034
Noncurrent Assets
Operating lease, right-of-use asset 230327618
Property, plant and equipment 8581,2261,4671,3941,030 
Intangible assets, net (including goodwill), including: 2,0612,0612,0612,0612,061 
Goodwill 2,0612,0612,0612,0612,061 
Intangible assets, net (excluding goodwill)     2,294 
Other undisclosed intangible assets, net (including goodwill)     (2,294) 
Deposits noncurrent assets 1717746868 
Other noncurrent assets      57
Total noncurrent assets: 3,1663,6314,2193,5233,15957
TOTAL ASSETS: 76,64226,61718,50318,38828,84917,091
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 10,6008639296538522,122
Interest and dividends payable 5973560  
Employee-related liabilities     579
Accrued liabilities      1,040
Other undisclosed accounts payable and accrued liabilities 10,600265894593852503
Debt  6223,6582,910  
Other liabilities 1162753056160 
Other undisclosed current liabilities 1,1631,7821,2021,109904 
Total current liabilities: 11,8793,5426,0934,7331,8162,122
Noncurrent Liabilities
Long-term debt and lease obligation   6224,2806,942 
Long-term debt, excluding current maturities   6224,2806,942 
Liabilities, other than long-term debt 12,9549,8258,6572,62215,385 
Other liabilities 13613440984142 
Derivative instruments and hedges, liabilities 12,8189,6918,2482,53715,243 
Other undisclosed noncurrent liabilities 1292,7961,56030990 
Total noncurrent liabilities: 13,08312,62110,8407,21122,416 
Total liabilities: 24,96216,16416,93311,94424,2322,122
Equity
Equity, attributable to parent 35,666(10,932)(12,092)6,4444,61614,969
Common stock 281499911
Additional paid in capital 183,91291,20374,83772,87171,94077,340
Accumulated deficit (148,274)(102,149)(86,938)(66,436)(67,332)(62,383)
Other undisclosed equity 16,01421,38513,662   
Total equity: 51,68010,4531,5706,4444,61614,969
TOTAL LIABILITIES AND EQUITY: 76,64226,61718,50318,38828,84917,091

Income Statement (P&L) ($ in thousands)

9/30/2022
TTM
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues 8,208243565753779 
Revenue, net779 
Sublease income 145243234
Cost of revenue (4,805)  (771)(320) 
Cost of goods and services sold    (771)(320) 
Gross profit: 3,403243565(18)459 
Operating expenses (44,193)(13,490)(14,768)(11,714)(16,626)(21,368)
Other undisclosed operating income (loss)  (213) 771320 
Operating loss: (40,790)(13,459)(14,202)(10,961)(15,848)(21,368)
Nonoperating income (expense) (5,335)(1,752)40511,858(419) 
Investment income, nonoperating   405298112 
Interest and debt expense  (308)(995)(1,146)(1,165) 
Loss from continuing operations before equity method investments, income taxes: (46,125)(15,519)(14,792)(249)(17,432)(21,368)
Other undisclosed income (loss) from continuing operations before income taxes  308(5,710)1,1461,165 
Income (loss) from continuing operations before income taxes: (46,125)(15,211)(20,502)896(16,267)(21,368)
Income tax expense (benefit) (6,413)(4,312)(8,892)(1,692)920 
Loss from continuing operations: (52,538)(19,522)(29,394)(795)(15,347)(21,368)
Loss before gain (loss) on sale of properties:(52,538)(19,522)(29,394)(795)(15,347)(21,368)
Net loss: (52,538)(19,522)(29,394)(795)(15,347)(21,368)
Other undisclosed net income attributable to parent 6,4134,3128,8921,692 47
Net income (loss) attributable to parent: (46,125)(15,211)(20,502)896(15,347)(21,321)
Preferred stock dividends and other adjustments (2,525)(1,737)(13,751)   
Net income (loss) available to common stockholders, diluted: (48,650)(16,948)(34,253)896(15,347)(21,321)

Comprehensive Income ($ in thousands)

9/30/2022
TTM
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss: (52,538)(19,522)(29,394)(795)(15,347)(21,368)
Comprehensive loss, net of tax, attributable to parent: (52,538)(19,522)(29,394)(795)(15,347)(21,368)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: